Get your COVID-19 vaccine or booster today!
Find out where to get a COVID-19 vaccine, test, or treatment in your community. Call 1-800-232-0233 with questions.
COVID.govFeatured Topics
Infant Formula Resources
The FDA continues to work around the clock with our government partners and industry to ensure there's adequate infant formula available wherever and whenever parents and caregivers need it.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
New Era of Smarter Food Safety
A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.
Recent Press Announcements
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Jul 06
Bumble Bee Foods, LLC Issues Voluntary Recall on 3.75 Oz Smoked Clams Due to the Presence of Detectable Levels of PFAS Chemicals
Food & Beverages
Jul 06
Primal Pet Foods Voluntary Recalls a Single Lot of Raw Frozen Patties Beef Formula Due to Potential Contamination with Listeria Monocytogenes
Animal & Veterinary
Jul 05
Mylan Pharmaceuticals Inc., a Viatris Company, Issues Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin glargine-yfgn) Injection Pens, 100 units/mL (U-100), Due to the Potential of Missing Labels on Some Pens
Drugs
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
FDA’s Center for Devices and Radiological Health’s Continued Efforts to Return to Normal: Reopening for All Pre-Submissions
We continue interactions with device submission sponsors as we work to return to normal operations while continuing to respond to the public health emergency.
FDA's “All-in” Approach to Enterprise Transformation
The Enterprise Modernization Action Plan is the next phase of FDA’s data and technology transformation and describes our plans to shape the agency’s future.
FDA Seeks to Engage Stakeholders on Key Considerations for a Drug Quality Management Maturity Program
Program Aims to Improve Drug Supply Chain, Mitigate Shortages
Recently Published Guidances
Jul 08
CVM GFI #245 Hazard Analysis and Risk-Based Preventive Controls for Food for Animals
Animal & Veterinary
Jul 06
DSCSA Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription Drugs Guidance for Industry
Drugs
Jul 05
Identifying Trading Partners Under the Drug Supply Chain Security Act
Drugs